Ascend Wellness Holdings (AAWH) Shares Outstanding (Weighted Average) (2020 - 2026)
Ascend Wellness Holdings (AAWH) recorded quarterly Shares Outstanding (Weighted Average) of $1.8 million in Q1 2026, little changed quarter-over-quarter from $1.8 million in Q4 2025, and down 43.88% on a YoY basis from $3.3 million in Q1 2025.
Ascend Wellness Holdings (AAWH) Shares Outstanding (Weighted Average) (2020 - 2026) Analysis & Trends
Ascend Wellness Holdings' Shares Outstanding (Weighted Average) history runs 7 years deep, the most recent figure standing at $1.8 million for Q1 2026.
- In Q1 2026, Shares Outstanding (Weighted Average) fell 43.88% year-over-year to $1.8 million; the TTM figure through Mar 2026 stood at $1.8 million (down 43.88% YoY), while the FY2025 annual figure was $203.5 million, up 6109.25% from the prior year.
- Shares Outstanding (Weighted Average) was $1.8 million for Q1 2026 at Ascend Wellness Holdings, roughly flat from $1.8 million in the prior quarter.
- In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $203.9 million in Q3 2025 to a low of $1.8 million in Q4 2025.
- Historically, Shares Outstanding (Weighted Average) has averaged $69.7 million across 5 years, with a median of $4.6 million in 2023.
- The sharpest annual moves came in 2024 and 2025: Shares Outstanding (Weighted Average) plunged 98.35% in 2024, then surged 4364.6% in 2025.
- A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $5.7 million in 2022, then soared by 3369.58% to $199.2 million in 2023, then slumped by 98.35% to $3.3 million in 2024, then sank by 43.88% to $1.8 million in 2025, then changed by 0.0% to $1.8 million in 2026.
- The last three Shares Outstanding (Weighted Average) figures came in at $1.8 million (Q1 2026), $1.8 million (Q4 2025), and $203.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 1.16 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 422.10 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 43.50 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 5.02 Bn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 100.50 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 497.70 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 166.20 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 228.36 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 64.74 Mn |
| 10 | Ascend Wellness Holdings | - | - | 44.88 Mn | 1.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.84 Mn |
| Dec 31, 2025 | 1.84 Mn |
| Sep 30, 2025 | 203.94 Mn |
| Jun 30, 2025 | 3.09 Mn |
| Mar 31, 2025 | 3.28 Mn |
| Dec 31, 2024 | 3.28 Mn |
| Sep 30, 2024 | 4.57 Mn |
| Jun 30, 2024 | 4.57 Mn |
| Mar 31, 2024 | 4.57 Mn |
| Dec 31, 2023 | 199.15 Mn |
| Sep 30, 2023 | 4.63 Mn |
| Jun 30, 2023 | 195.65 Mn |
| Mar 31, 2023 | 188.49 Mn |
| Dec 31, 2022 | 5.74 Mn |
| Sep 30, 2022 | 181.83 Mn |
| Jun 30, 2022 | 5.90 Mn |
| Mar 31, 2022 | 172.49 Mn |
| Dec 31, 2021 | 3.53 Mn |
| Sep 30, 2021 | 169.88 Mn |
| Jun 30, 2021 | 150.34 Mn |